Published in Urology on July 16, 2009
Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discov (2013) 1.03
Markers of field cancerization: proposed clinical applications in prostate biopsies. Prostate Cancer (2012) 1.00
Organ-wide telomeric status in diseased and disease-free prostatic tissues. Prostate (2010) 0.90
Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. Prostate (2011) 0.89
Prostate cancer: the need for biomarkers and new therapeutic targets. J Zhejiang Univ Sci B (2014) 0.82
Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. PLoS One (2015) 0.81
Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence. Prostate Cancer Prostatic Dis (2015) 0.76
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Prostate (2015) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Natural history of progression after PSA elevation following radical prostatectomy. JAMA (1999) 14.35
p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell (1999) 5.93
A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res (2003) 5.04
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst (1999) 3.35
Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A (2001) 2.91
Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res (2004) 2.84
Telomere dysfunction increases mutation rate and genomic instability. Cell (2001) 2.62
Measurement of telomeric DNA content in human tissues. Biotechniques (1997) 2.31
Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure. J Clin Oncol (2005) 1.98
Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett (2003) 1.57
Telomeres: prognostic markers for solid tumors. Int J Cancer (2006) 1.44
The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection. Cancer Res (2005) 1.38
Association between cancer-free survival and telomere DNA content in prostate tumors. J Urol (2005) 1.21
Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials. Eur J Cancer (2006) 1.18
Critical telomere shortening regulated by the ataxia-telangiectasia gene acts as a DNA damage signal leading to activation of p53 protein and limited life-span of human diploid fibroblasts. A review. Biochemistry (Mosc) (1997) 1.05
Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer. Neoplasia (2007) 1.00
Association between outcome and telomere DNA content in prostate cancer. J Urol (1999) 0.97
Chemiluminescent measurement of telomere DNA content in biopsies. Biotechniques (2002) 0.89
Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database. Prostate Cancer Prostatic Dis (2008) 0.87
Tracking the clonal origin of lethal prostate cancer. J Clin Invest (2013) 5.79
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget (2012) 3.88
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc Natl Acad Sci U S A (2011) 2.12
Randomized evaluation of a web based interview process for urology resident selection. J Urol (2012) 1.95
Telomere length as a risk factor for hereditary prostate cancer. Prostate (2013) 1.50
Effect of strenuous exercise on urine concentrations of homovanillic acid, cortisol, and vanillylmandelic acid in sled dogs. Am J Vet Res (2007) 1.48
Telomeres: prognostic markers for solid tumors. Int J Cancer (2006) 1.44
Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Res Treat (2009) 1.40
Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Bull (2009) 1.32
Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res Treat (2006) 1.27
Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer (2006) 1.25
Association between cancer-free survival and telomere DNA content in prostate tumors. J Urol (2005) 1.21
Glomerulonephritis causing acute renal failure during the course of bacterial infections. Histological varieties, potential pathogenetic pathways and treatment. Int Urol Nephrol (2008) 1.14
Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Mol Imaging (2007) 1.12
Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imaging. J Nanopart Res (2011) 1.12
Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer (2011) 1.09
Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression. Brain Behav Immun (2012) 1.07
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol (2012) 1.06
Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol (2012) 1.04
1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells. Prostate (2008) 1.00
The Akt C-terminal modulator protein is an acyl-CoA thioesterase of the Hotdog-Fold family. Biochemistry (2009) 1.00
Markers of field cancerization: proposed clinical applications in prostate biopsies. Prostate Cancer (2012) 1.00
The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression. Mod Pathol (2009) 0.96
Assessment of alterations in triglyceride and glycogen concentrations in muscle tissue of Alaskan sled dogs during repetitive prolonged exercise. Am J Vet Res (2008) 0.95
AsialoGM1 and integrin alpha2beta1 mediate prostate cancer progression. Int J Oncol (2009) 0.94
Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells. Lipids Health Dis (2012) 0.94
Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells. Int J Cancer (2013) 0.94
Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion. Int J Cancer (2012) 0.93
Telomere DNA content predicts breast cancer-free survival interval. Clin Cancer Res (2007) 0.91
Organ-wide telomeric status in diseased and disease-free prostatic tissues. Prostate (2010) 0.90
Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels. Int J Cancer (2003) 0.90
Leucine treatment enhances oxidative capacity through complete carbohydrate oxidation and increased mitochondrial density in skeletal muscle cells. Amino Acids (2013) 0.90
Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues. Mol Cancer Res (2005) 0.90
Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. Prostate (2011) 0.89
Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias. Mod Pathol (2010) 0.89
Chemiluminescent measurement of telomere DNA content in biopsies. Biotechniques (2002) 0.89
Collection and characterisation of bacterial membrane proteins. FEBS Lett (2003) 0.87
A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma. J Urol (2005) 0.87
Protease nexin-1 expression is altered in human breast cancer. Cancer Cell Int (2006) 0.87
Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955. J Urol (2004) 0.87
Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells. Prostate (2013) 0.86
Serum chemistry alterations in Alaskan sled dogs during five successive days of prolonged endurance exercise. J Am Vet Med Assoc (2007) 0.86
Efficacy of famotidine for the prevention of exercise-induced gastritis in racing Alaskan sled dogs. J Vet Intern Med (2007) 0.84
The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol (2012) 0.84
Genomic instability demonstrates similarity between DCIS and invasive carcinomas. Breast Cancer Res Treat (2008) 0.84
A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model. Mol Cell Biochem (2006) 0.84
Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization. Mol Pharm (2014) 0.83
Breast field cancerization: isolation and comparison of telomerase-expressing cells in tumor and tumor adjacent, histologically normal breast tissue. Mol Cancer Res (2011) 0.82
A glioblastoma neurosphere line with alternative lengthening of telomeres. Acta Neuropathol (2013) 0.82
The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer. Prostate (2008) 0.81
SEER coding standards result in underestimation of positive surgical margin incidence at radical prostatectomy: results of a systematic audit. J Urol (2011) 0.81
Treatment of human muscle cells with popular dietary supplements increase mitochondrial function and metabolic rate. Nutr Metab (Lond) (2012) 0.81
Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses. J Vet Intern Med (2006) 0.80
Effects of caffeine on metabolism and mitochondria biogenesis in rhabdomyosarcoma cells compared with 2,4-dinitrophenol. Nutr Metab Insights (2012) 0.80
Human brown fat inducible thioesterase variant 2 cellular localization and catalytic function. Biochemistry (2012) 0.80
The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells. Prostate (2011) 0.80
Assessment of the frequency of allelic imbalance in human tissue using a multiplex polymerase chain reaction system. J Mol Diagn (2007) 0.79
Evidence-based respiratory medicine in horses. Vet Clin North Am Equine Pract (2007) 0.79
Immunoglobulin A nephropathy complicating ulcerative colitis. Int Urol Nephrol (2006) 0.79
Dietary stimulators of the PGC-1 superfamily and mitochondrial biosynthesis in skeletal muscle. A mini-review. J Physiol Biochem (2013) 0.79
Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer (2014) 0.79
Scavenger receptor block as strategy for the identification of bone marrow homing phages by panning in vivo random peptide phage displayed libraries. J Immunol Methods (2002) 0.79
What we have learned from randomized trials of prostate cancer screening. Asian J Androl (2011) 0.78
Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis. Eur J Pharmacol (2013) 0.78
Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features. Mod Pathol (2013) 0.77
Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas. Cancer Med (2012) 0.77
β-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro. Mol Cancer (2014) 0.77
Peptabodies as tools to test ligands isolated from phage-displayed peptide libraries. J Immunol Methods (2003) 0.76
Percutaneous ureteral elevation in laparoendoscopic single-site radical nephrectomy. JSLS (2011) 0.75